Recent Company News

• 02:51 AM ET Feb 16, 2026
  

  StreetAccount Summary - European pre-market trading update

• 11:52 AM ET Feb 13, 2026
  

  Valneva updates on recommendations for use of IXCHIQ in UK (€4.36, 0.00)

• 07:06 AM ET Jan 07, 2026
  

  StreetAccount Summary - European unusual volume traders

• 04:12 AM ET Jan 06, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 01:04 AM ET Feb 03, 2026
  

  Valneva announced the initiation of a Pilot Vaccination Strategy (PVS) in Brazil using Valneva's single-shot chikungunya vaccine IXCHIQ (€3.91, 0.00)

• 12:04 PM ET Jan 19, 2026
  

  Valneva to voluntarily withdraw BLA and IND application for its chikungunya vaccine, IXCHIQ, in the United States, following suspension of the license by the FDA in Aug-25 (€4.22, 0.00)